急性冠脉综合征合并缺血性二尖瓣反流:单纯血运重建的结局
该单中心回顾性研究评估急性冠脉综合征合并缺血性二尖瓣反流患者仅行冠脉血运重建(不同期行二尖瓣手术)的2年结局。按反流程度分为II级组(n=117)和III-IV级组(n=40),II级组反流改善率显著高于III-IV级组(70.9% vs 30%,P < .001)。结论:单纯血运重建对III或IV级缺血性二尖瓣反流治疗不足,需额外治疗选项。
要点
- 急性冠脉综合征合并缺血性二尖瓣反流仅行血运重建时,II级反流改善率70.9%,III-IV级仅30%。
- II级组中左室逆重构(OR 5.712,95%CI 1.716-19.046,P = .005)和心衰有效管理(OR 3.900,95%CI 1.322-11.501,P = .01)是反流改善的预测因素。
- III-IV级组未发现反流改善的显著预测因素,包括左室逆重构(OR 6.302,95%CI 0.476-71.800,P = .17)。
核心结论
- 急性冠脉综合征合并缺血性二尖瓣反流患者中,单纯冠脉血运重建对III或IV级反流治疗不足,需额外治疗选项。
研究设计与样本
- 单中心回顾性研究,纳入因急性冠脉综合征行冠脉血运重建而未同期行二尖瓣手术的缺血性二尖瓣反流患者。
- 按反流严重程度分组:II级组n=117,III-IV级组n=40。
- 主要终点为2年时二尖瓣反流严重程度改善。
主要发现
- 两组基线特征无显著差异。
- II级组反流改善率显著高于III-IV级组(70.9% vs 30%,P < .001)。
- II级组中左室逆重构(OR 5.712,95%CI 1.716-19.046,P = .005)和心衰有效管理(OR 3.900,95%CI 1.322-11.501,P = .01)是反流改善的显著预测因素。
- III-IV级组中包括左室逆重构(OR 6.302,95%CI 0.476-71.800,P = .17)在内的因素均非反流改善的显著预测因素。
临床怎么用
- 对于急性冠脉综合征合并III或IV级缺血性二尖瓣反流患者,单纯冠脉血运重建可能不足以改善反流,应考虑额外治疗选项。
- 对于II级缺血性二尖瓣反流患者,促进左室逆重构和有效管理心力衰竭可能有助于反流改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ischemic mitral regurgitation impacts patient survival and quality of life due to left ventricular remodeling post-myocardial infarction. However, effective treatment strategies for this condition, particularly in the setting of acute coronary syndrome, remain insufficiently evidenced. In this article, we provide treatment references for the management of ischemic mitral regurgitation in patients with acute coronary syndrome. METHODS: In this single-center retrospective study, we evaluated patients with ischemic mitral regurgitation who underwent coronary revascularization for acute coronary syndrome without concurrent mitral valve surgery. Patients were categorized into 2 groups based on mitral regurgitation severity: grade II (grade II ischemic mitral regurgitation, n = 117) and grade III-IV (grade III or IV ischemic mitral regurgitation, n = 40). The primary end point was the improvement in mitral regurgitation severity at 2 years. RESULTS: Baseline characteristics did not differ significantly between the groups. Ischemic mitral regurgitation significantly improved in the grade II group compared with the grade III-IV group (70.9% vs 30%, P < .001). Multivariate analyses revealed that left ventricular reverse remodeling (odds ratio, 5.712; 95% CI, 1.716-19.046; P = .005) and effective management of congestive heart failure (odds ratio, 3.900; 95% CI, 1.322-11.501; P = .01) were significant predictors of ischemic mitral regurgitation improvement in the grade II group. However, there were no significant predictors of ischemic mitral regurgitation improvement in the grade III-IV group, including left ventricular reverse remodeling (odds ratio, 6.302; 95% CI, 0.476-71.800; P = .17). CONCLUSIONS: In patients with acute coronary syndrome and ischemic mitral regurgitation, coronary revascularization alone was insufficient for treating advanced ischemic mitral regurgitation, grade III or IV, necessitating additional treatment options for ischemic mitral regurgitation.
引用
- Chae M, Yoon S, Lee HJ, et al. Outcomes of ischemic mitral regurgitation after coronary revascularization alone in patients with acute coronary syndrome. J Thorac Cardiovasc Surg. 2025. PMID: 40286983. doi:10.1016/j.jtcvs.2025.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。